If you’re looking for an Assistant Professor position, in immunology, metabolism, and aging- come join us in Madison! The metabolism community is outstanding and spans the entire campus.
https://t.co/tq7cq5sPLL
Cardiac PGC1a is required for adaptations of the heart to exercise (in mice). A wonderful collaboration with the lab of Tony Rosenzweig. Sumeet is off to start his won lab at UVa (congrats!) https://t.co/gR7B2QuLIt
The passing Of Dave Mangelsdorf is a terrible loss for his family, friends and the science world. Davo will never be forgotten. 😢 https://t.co/JQzVDG9RWS
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Read the full study by @DanielJDrucker & colleagues in @Cell_Metabolism#ENDO2025 https://t.co/G0WrCEE2Oz
🚨New from our group in @CircRes
We identify a FoxO1-zDHHC4-CD36 S-acylation axis driving metabolic + contractile dysfunction in the diabetic heart.
Blocking this pathway reprograms FA metabolism and improves heart function.
Read more:
🔗 https://t.co/eDblIq3pnt
Same spot, 3 days later, after an amazing conference and…a best ECI presentation award! Thank you again @ishr2025@QKarwi for the opportunity to present some of my research in the @JussherLab. Had a great time reconnecting with old colleagues and getting to meet some new ones!
Grateful to @JussherLab Jordan SF Chan & @AmDiabetesAssn for featuring our T2D cardiomyopathy model in their editorial.Of Mice and Men: Toward a Better Model of Diabetic Cardiomyopathy With Application in Female Animals https://t.co/UcZSAxPpwk @QMULWHRI@wellcometrust
Here it is proposed that halofuginone, a FDA–approved anti-scleroderma and antiprotozoal drug, is a promising anti-#obesity agent acting via FGF-21 and GDF-15 in preclinical mouse and pig models @ScienceAdvances#weightloss https://t.co/rmRSPkdSJG
A big CONGRATS to @JordanSFChan , who successfully passed his #CandidacyExam this morning! Really proud seeing how much he has matured as a #scientist since joining the lab May 2021
So this Monday was the 10 year #anniversary of the lab (time flies!!) and a very eventful week, starting with a presentation on #GLP1 receptor agonists and #cardiovascular#outcomes at the fantastic @MacMODR Annual Research Symposium
New anti-obesity drug shows promise in preventing heart failure related to Type 2 diabetes.
John Ussher finds experimental weight loss drug GDF15 improves heart function in mice with diabetes, independent of its weight loss effects.
@JussherLab
https://t.co/hSBwsn13qz
It’s been an incredible journey completing my PhD at @JussherLab . Excited to start my postdoc at @DrGregSteinberg lab! I wasn’t expecting this but I’m honored to receive #CIHR Postdoctoral Fellowship. Thanks to @CIHR_IRSC for this opportunity. Looking forward to the new chapter